Moderna to start late-stage trial testing of COVID-19 vaccine on July 27
- 4 years ago
모더나, 27일부터 코로나 백신 3상 임상시험…3만명 대상
U.S. biotech company Moderna will begin late-stage trial testing of a potential COVID-19 vaccine on July 27th.
According to a U.S. government registry of drug trials ClinicalTrials.gov on Tuesday, the trial will enroll 30-thousand participants across thirty states and Washington, D.C. including California and Florida.
Participants will receive a 100 microgram dose on the first day of the experiment and another 29 days later.
Some patients will receive a placebo.
In May, Moderna released data from its early stage trial that said the potential vaccine produced neutralizing antibodies as well as binding antibodies in all participants.
U.S. biotech company Moderna will begin late-stage trial testing of a potential COVID-19 vaccine on July 27th.
According to a U.S. government registry of drug trials ClinicalTrials.gov on Tuesday, the trial will enroll 30-thousand participants across thirty states and Washington, D.C. including California and Florida.
Participants will receive a 100 microgram dose on the first day of the experiment and another 29 days later.
Some patients will receive a placebo.
In May, Moderna released data from its early stage trial that said the potential vaccine produced neutralizing antibodies as well as binding antibodies in all participants.